The impact of multiple low-level BCR-ABL1 mutations on response to ponatinib

Wendy T Parker(University of South Australia), Susan Branford(South Australia Pathology), Chani Field(South Australia Pathology), Haley Altamura(South Australia Pathology), John Hodgson(University of Sheffield), Victor M. Rivera(Ariadne Diagnostics (United States)), Timothy P. Hughes(Royal Adelaide Hospital), Bronte A. Jamison(South Australia Pathology), David T Yeung(Royal Adelaide Hospital), Alexandra L. Yeoman(South Australia Pathology), Stephanie Lustgarten(Ariadne Diagnostics (United States))
Blood
January 16, 2016
Cited by 65


Related Papers